Interested in being a part of the Diagnostic Revolution? Learn more about investment opportunities here.

Newsfeed

Press Releases

Medical Funding Professionals logo

JUNE 15, 2022

Facible Engages Medical Funding Professionals to Implement Capital Planning Valuation Strategy™

Medical Funding Professionals (MFP) is pleased to announce that Facible Biodagnostics has engaged MFP to implement the Capital Planning Valuation Strategy™ Co-Chaired by Scott Pantel of LSI and Stephen Brock of MFP in preparation of the company’s Regulation A+ offering.

NIH logo

APRIL 1, 2021

Facible Awarded Second National Institutes of Health Grant to Advance Rapid Test for SARS-CoV-2 (COVID-19)

Facible Biodiagnostics announces an additional $521,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.

NIH logo

DECEMBER 15, 2020

Facible Awarded National Institutes of Health Grant to Advance Rapid Test for SARS-CoV-2 (COVID-19)

Facible Biodiagnostics, a purpose-driven startup company focused on creating fast, accurate and affordable hospital-grade biodiagnostic tests, today announced a $250,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.

For press inquires, please contact:

Phone icon

1-208-567-8910

Envelope icon

Travis Nilsson, CMO - travis.nilsson@facible.com